Fredun Pharmaceuticals has launched “Hormone Range Products,” a premium speciality therapeutics brand focused on longevity, hormone health, recovery science and human performance solutions.
The move marks Fredun’s strategic entry into a rapidly expanding, high-value healthcare segment driven by increasing global demand for preventive, performance-oriented, and precision-based therapeutics.
Built on a doctor-led, ethical and evidence-backed pharmaceutical model, the hormone range products combine clinical credibility with a digital-first patient and doctor engagement ecosystem to deliver an integrated healthcare experience focused on outcomes, adherence, and long-term patient value.
Shift towards preventive and performance-based healthcare
The range is designed to address the growing shift from traditional disease management to healthy lifespan optimisation, preventive care, and advanced performance therapeutics, the company said.
The initial portfolio includes therapies and formulations based on testosterone and its salts, nandrolone, growth hormone-oriented solutions and supportive hormone optimisation therapies, developed to meet specialised clinical requirements under appropriate medical supervision. The platform is further supported by protocol-driven patient monitoring, doctor engagement, and direct-to-patient fulfilment capabilities designed to improve treatment continuity and patient adherence.
Leveraging pharma expertise for premium therapeutics growth
The brand leverages Fredun Pharmaceuticals’ established strengths in pharmaceutical formulation development, quality-focused manufacturing and global distribution capabilities, while creating new opportunities in premium, innovation-driven therapeutic segments.
With increasing consumer and medical focus on vitality, metabolic health, recovery science, and preventive wellness, Fredun believes its hormone range products are well-positioned to address an evolving market opportunity through a trusted, outcomes-focused, and ethically driven pharmaceutical approach.
Management vision for high-science healthcare expansion
Fredun Medhora, Managing Director, Fredun Pharmaceuticals, said as the company moves up the value chain, the focus will be on entering segments that demand high scientific rigour, clinical validation and manufacturing excellence.
The product range reflects the company’s vision to bring medical expertise and evidence-based formulations together for creating a credible presence in hormone and performance therapeutics, he added.
Published on May 16, 2026